Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GHTF Compromise On Use Error Adverse Event Reporting To Be Studied In June

This article was originally published in The Gray Sheet

Executive Summary

Device manufacturers should only have to report adverse events involving use error when there is death or serious injury, according to a proposal under consideration by the Global Harmonization Task Force's Study Group Two (SG2).

You may also be interested in...



GHTF Proposal On Reporting "Use Errors" Hurts Safety - Public Citizen

A proposal under consideration by the Global Harmonization Task Force's Study Group Two which would not require reporting of adverse events involving device use errors that do not result in death or serious injury represents "a significant weakening of current standards" and should not be implemented, according to consumer advocacy group Public Citizen.

Finance Watch: Silverback, Kinnate, Sigilon Launch December’s First IPOs

Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.

UsernamePublicRestriction

Register

LL1134940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel